ExLibris header image
SFX Logo
Title: VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Takahashi, N yr:1997


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Wang, Y M M. "Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine." Neuron 19.6 (1997): 1285-96. Link to SFX for this item
2. Patel, J. "Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice." Journal of neurochemistry 85.4 (2003): 898-910. Link to Full Text for this item Link to SFX for this item
3. Hantrave, P. "Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons." Nature medicine 2.9 (1996): 1017-21. Link to Full Text for this item Link to SFX for this item
4. Langston, J W W. "Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis." Science 219.4587 (1983): 979-80. Link to SFX for this item
5. Tatsumi, M. "Pharmacological profile of neuroleptics at human monoamine transporters." European journal of pharmacology 368.2-3 (1999): 277-83. Link to Full Text for this item Link to SFX for this item
6. Fon, E A A. "Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action." Neuron 19.6 (1997): 1271-83. Link to SFX for this item
7. Gainetdinov, R R R. "Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter." Journal of neurochemistry 69.3 (1997): 1322-5. Link to Full Text for this item Link to SFX for this item
8. Nicklas, W J J. "Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine." Life Sciences 36.26 (1985): 2503-8. Link to Full Text for this item Link to SFX for this item
9. Marsden, C D D. "Mitochondrial complex I deficiency in Parkinson's disease." Lancet, The 1.8649 (1989): 1269-1269. Link to SFX for this item
10. Dauer, W. "Parkinson's Disease Mechanisms and Models." Neuron 39.6 (2003): 889-909. Link to SFX for this item
11. Owens, Michael J. "Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites." The Journal of pharmacology and experimental therapeutics 283.3 (1997): 1305-22. Link to SFX for this item
12. Cusack, B. "Binding of antidepressants to human brain receptors: focus on newer generation compounds." Psychopharmacology 114.4 (1994): 559-565. Link to Full Text for this item Link to SFX for this item
13. Mooslehner, K A A. "Mice with very low expression of the vesicular monoamine transporter 2 gene survive into adulthood: Potential mouse model for parkinsonism." Molecular and cellular biology 21.16 (2001): 5321-5331. Link to Full Text for this item Link to SFX for this item
14. Mosharov, David V. "alpha-synuclein overexpression increases cytosolic catecholamine concentration." The journal of neuroscience 26.36 (2006): 9304-9311. Link to Full Text for this item Link to SFX for this item
15. Shen, H. "Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters." Neuropsychopharmacology 29.10 (2004): 1790-9. Link to Full Text for this item Link to SFX for this item
16. Wise, G W W. "Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct." Science 272.5269 (1996): 1791-4. Link to SFX for this item
17. BURNS, R S S. "A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE." Proceedings of the National Academy of Sciences of the United States of America 80.14 (1983): 4546-4550. Link to Full Text for this item Link to SFX for this item
18. Sonsalla, P K A. "Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations." Journal of neurochemistry 74.5 (2000): 2217-20. Link to Full Text for this item Link to SFX for this item
19. Yamamoto, H. "Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture." Neurochemistry International 51.2-4 (2007): 237-44. Link to SFX for this item
20. Curtis, M. "Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain." Proceedings of the National Academy of Sciences of the United States of America 100.15 (2003): 9023-7. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.